FMCG
Honasa Called Off a ₹135 Crore Acquisition Two Months After Announcing It
Mamaearth's parent walked away from buying 58% of Fluence Pharma over an unmet closing condition it hasn't named. The company's stock is near a 52-week high and its profit just nearly tripled, so this reads as discipline, not distress.